A Aforeworn
Forewarned is forearmed.
Home › Niches › Pharmaceutical Manufacturing (FDA/DEA) › Change
Low urgency

AZ HB2007: ivermectin; over-the-counter drug

Detected August 3, 2026 · in Pharmaceutical Manufacturing (FDA/DEA)

Arizona House Bill 2007 proposes to make ivermectin available over-the-counter, potentially affecting FDA-regulated manufacturing, labeling, and distribution requirements.

Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on August 3, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, and compounding outsourcing facilities (503B) that manufacture or distribute ivermectin products in Arizona. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No specific deadline provided; monitor legislative session.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

The bill, if enacted, would allow ivermectin to be sold without a prescription in Arizona, which could alter the regulatory landscape for manufacturing, labeling, and distribution.

Who it affects

Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, and compounding outsourcing facilities (503B) that manufacture or distribute ivermectin products in Arizona.

What you must do

Monitor the bill's progress and assess potential impacts on current manufacturing and distribution practices.

Deadline

No specific deadline provided; monitor legislative session.

Source: https://www.azleg.gov/bills/

Never miss a change like this again

Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmaceutical Manufacturing (FDA/DEA)